Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/29366
Type
ArticleCopyright
Open access
Sustainable Development Goals
03 Saúde e Bem-EstarCollections
Metadata
Show full item record62
CITATIONS
62
Total citations
13
Recent citations
12
Field Citation Ratio
1.44
Relative Citation Ratio
VISCEROTROPIC DISEASE: CASE DEFINITION AND GUIDELINES FOR COLLECTION, ANALYSIS, AND PRESENTATION OF IMMUNIZATION SAFETY DATA
Vacina contra Febre Amarela
Acontecimento adverso
Imunização
Guia
Definição de caso
Yellow fever vaccine
Adverse event
Immunization
Guideline
Case definition
Author
Gershman, Mark D.
Staples, J. Erin
Bentsi-Enchill, Adwoa D.
Breugelmans, J. Gabrielle
Brito, Glacus S.
Camacho, Luiz Antonio Bastos
Cotting, Pascale
Domingo, Cristina
Durbin, Anna
Gascon, Joaquim
Guenaneche, Fouzia
Hayes, Edward B.
Jelenik, Zsuzsanna
Khromava, Alena
Martins, Reinaldo de Menezes
Wilson, Mario Masana
Massy, Nathalie
Nasidi, Abdulsalami
Niedrig, Matthias
Sherwat, Adam
Tsai, Theodore
Vilella, Anna
Wilson, Mary Elizabeth
Koh, Katrin S.
Staples, J. Erin
Bentsi-Enchill, Adwoa D.
Breugelmans, J. Gabrielle
Brito, Glacus S.
Camacho, Luiz Antonio Bastos
Cotting, Pascale
Domingo, Cristina
Durbin, Anna
Gascon, Joaquim
Guenaneche, Fouzia
Hayes, Edward B.
Jelenik, Zsuzsanna
Khromava, Alena
Martins, Reinaldo de Menezes
Wilson, Mario Masana
Massy, Nathalie
Nasidi, Abdulsalami
Niedrig, Matthias
Sherwat, Adam
Tsai, Theodore
Vilella, Anna
Wilson, Mary Elizabeth
Koh, Katrin S.
Affilliation
Centers for Disease Control and Prevention. Division of Global Migration and Quarantine. National Center for Emerging and Zoonotic Infectious Diseases. Atlanta, GA, USA. / Centers for Disease Control and Prevention. Division of Vector-Borne Diseases. National Center for Emerging and Zoonotic Infectious Diseases. Fort Collins, CO, USA.
World Health Organization. Department of Immunization, Vaccines, and Biologicals. Geneva, Switzerland.
Institut Pasteur. Agence de Médecine Préventive. Paris, France.
Hospital das Clinicas. Division of Clinical Immunology and Allergy. São Paulo, SP, Brasil.
Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública. Rio de Janeiro, Brasil.
Sanofipasteur. Global Pharmacovigilance & Epidemiology. Lyon, France. Robert Koch Institute. Berlin, Germany. / Sanofipasteur. Division of Safety Monitoring and Risk Management for Pediatric and Travel Vaccines. Lyon, France.
Department of International Health. Center for Immunization Research. Johns Hopkins Bloomberg School of Public Health. Baltimore, MD, USA.
Barcelona Centre for International Health Research. Barcelona, Espanha.
National Centre of Epidemiology. International Traveller’s Health and Vaccination Centre. Budapest, Hungary.
Sanofipasteur. Global Pharmacovigilance and Epidemiology Department. Toronto, Canada.
Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.
Ministry of Health. Epidemiology Direction. Buenos Aires Province, Argentina.
Rouen University Hospital. Pharmacovigilance Regional Center of Upper-Normandy. Rouen, Cedex, France.
Federal Ministry of Health. Federal Secretariat. Maitama, Abuja, Nigeria.
National Institutes of Health. National Institute of Allergy and Infectious Diseases. Division of AIDS. Bethesda, USA.
Novartis Vaccines. Cambridge, USA.
Harvard School of Public Health. Department of Global Health and Population. Boston, USA.
World Health Organization. Department of Immunization, Vaccines, and Biologicals. Geneva, Switzerland.
Institut Pasteur. Agence de Médecine Préventive. Paris, France.
Hospital das Clinicas. Division of Clinical Immunology and Allergy. São Paulo, SP, Brasil.
Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública. Rio de Janeiro, Brasil.
Sanofipasteur. Global Pharmacovigilance & Epidemiology. Lyon, France. Robert Koch Institute. Berlin, Germany. / Sanofipasteur. Division of Safety Monitoring and Risk Management for Pediatric and Travel Vaccines. Lyon, France.
Department of International Health. Center for Immunization Research. Johns Hopkins Bloomberg School of Public Health. Baltimore, MD, USA.
Barcelona Centre for International Health Research. Barcelona, Espanha.
National Centre of Epidemiology. International Traveller’s Health and Vaccination Centre. Budapest, Hungary.
Sanofipasteur. Global Pharmacovigilance and Epidemiology Department. Toronto, Canada.
Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.
Ministry of Health. Epidemiology Direction. Buenos Aires Province, Argentina.
Rouen University Hospital. Pharmacovigilance Regional Center of Upper-Normandy. Rouen, Cedex, France.
Federal Ministry of Health. Federal Secretariat. Maitama, Abuja, Nigeria.
National Institutes of Health. National Institute of Allergy and Infectious Diseases. Division of AIDS. Bethesda, USA.
Novartis Vaccines. Cambridge, USA.
Harvard School of Public Health. Department of Global Health and Population. Boston, USA.
Keywords in Portuguese
Doença viscerotrópicaVacina contra Febre Amarela
Acontecimento adverso
Imunização
Guia
Definição de caso
Keywords
Viscerotropic diseaseYellow fever vaccine
Adverse event
Immunization
Guideline
Case definition
Share